Serum uric acid levels and cancer mortality risk among males in a large general population-based cohort study

Tumour Lysis Syndrome: Implications for Cancer Therapy

(2013) Denish Mika et al.   Asian Pacific Journal of Cancer Prevention

Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies

(2013) Gang Zhao et al.   ATHEROSCLEROSIS

Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal?

(2013) Zohreh Soltani et al.   CURRENT HYPERTENSION REPORTS

The role of uric acid in the pathogenesis of human cardiovascular disease

(2013) Mehmet Kanbay et al.   HEART

Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study

(2012) Sylwia M. Figarska et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality

(2012) C.-F. Kuo et al.   RHEUMATOLOGY

Is there anything good in uric acid?

(2011) B. Alvarez-Lario et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

The Epidemiology of Uric Acid and Fructose

(2011) Young Hee Rho et al.   SEMINARS IN NEPHROLOGY

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer

(2010) Anthony W. Kim et al.   LUNG CANCER

Use of Penalized Splines in Extended Cox-Type Additive Hazard Regression to Flexibly Estimate the Effect of Time-varying Serum Uric Acid on Risk of Cancer Incidence: A Prospective, Population-Based Study in 78,850 Men

(2008) Alexander M. Strasak et al.   ANNALS OF EPIDEMIOLOGY

Xanthine oxidoreductase – Clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells

(2008) Nina Linder et al.   EUROPEAN JOURNAL OF CANCER